Jubilant Pharmova board approves slump sale of API business to subsidiary Jubilant Biosys

The API division recorded a turnover of ₹609 crore in FY25, accounting for 8.35% of the company’s consolidated revenue. Its net worth stood at ₹666.5 crore as of March 31, 2025, contributing 10.68% of the company’s consolidated net worth. Shares…








